King C. P. Li

King C. P. Li

Auto-generated profile, based on publicly available information

King C. P. Li

Department of Radiology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1998 in Nature Medicine
Verified
Journal Article
Closed access
DSDorothy A. Sipkins
Dorothy A. Sipkins
DCDavid A. Cheresh
David A. Cheresh
MKMahmood R. Kazemi
Mahmood R. Kazemi
LNLinda M. Nevin
Linda M. Nevin
MBMark D. Bednarski
Mark D. Bednarski
KLKing C.P. Li
King C.P. Li

1 May 2007 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
SDSergio Dromi
Sergio Dromi
VFVictor Frenkel
Victor Frenkel
ALAlfred Luk
Alfred Luk
BTBryan Traughber
Bryan Traughber
MAMary Angstadt
Mary Angstadt
BWBradford J Wood
Bradford J Wood
Purpose: To determine if pulsed-high intensity focused ultrasound (HIFU) could effectively serve as a source of hyperthermia with thermosensitive liposomes to enhance delivery and efficacy of doxorubicin in tumors. Experimental Design: Comparisons in vitro and in vivo were carried out between non–thermosensitive liposomes (NTSL) and low temperature–sensitive liposomes (LTSL). Liposomes were incubated in vitro over a range of temperatures and durations, and the amount of doxorubicin released was measured. For in vivo experiments, liposomes and free doxorubicin were injected i.v. in mice followed by pulsed-HIFU exposures in s.c. murine adenocarcinoma tumors at 0 and 24 h after administration. Combinations of the exposures and drug formulations were evaluated for doxorubicin concentration and growth inhibition in the tumors. Results:In vitro incubations simulating the pulsed-HIFU thermal dose (42°C for 2 min) triggered release of 50% of doxorubicin from the LTSLs; however, no detectable release from the NTSLs was observed. Similarly, in vivo experiments showed that pulsed-HIFU exposures combined with the LTSLs resulted in more rapid delivery of doxorubicin as well as significantly higher i.t. concentration when compared with LTSLs alone or NTSLs, with or without exposures. Combining the exposures with the LTSLs also significantly reduced tumor growth compared with all other groups. Conclusions: Combining low-temperature heat-sensitive liposomes with noninvasive and nondestructive pulsed-HIFU exposures enhanced the delivery of doxorubicin and, consequently, its antitumor effects. This combination therapy could potentially produce viable clinical strategies for improved targeting and delivery of drugs for treatment of cancer and other diseases.

1 September 1997 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
AKAdam B. Kerr
Adam B. Kerr
JPJohn M. Pauly
John M. Pauly
BHBob S. Hu
Bob S. Hu
KLKing C. Li
King C. Li
CHChristopher J. Hardy
Christopher J. Hardy
DNDwight G. Nishimura
Dwight G. Nishimura

1 July 1995 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
KHKatharine L. Hopkins
Katharine L. Hopkins
KLKing C. P. Li
King C. P. Li
GBGabrielle Bergman
Gabrielle Bergman

1 April 2006 in Academic Radiology
Verified
Journal Article
Closed access
VFVictor Frenkel
Victor Frenkel
AEAmena Etherington
Amena Etherington
MGMaiya Greene
Maiya Greene
JQJade Quijano
Jade Quijano
JXJianwu Xie
Jianwu Xie
KLKing C.P. Li
King C.P. Li

1 April 2000 in Journal of Neuroimmunology
Verified
Journal Article
Open access
DSDorothy A Sipkins
Dorothy A Sipkins
KGKoenraad Gijbels
Koenraad Gijbels
FTFrançois D Tropper
François D Tropper
MBMark Bednarski
Mark Bednarski
KLKing C.P Li
King C.P Li
LSLawrence Steinman
Lawrence Steinman
The expression of leukocyte adhesion molecules in the intact brains of mice with experimental autoimmune encephalitis (EAE) was visualized by Magnetic Resonance Imaging (MRI) through the use of a new, target-specific MR contrast agent. Antibody-conjugated paramagnetic liposomes (ACPLs) were designed to achieve in vivo targeting of molecules expressed on vascular endothelium, while providing sufficient signal enhancement at these sites for detection by MRI. ACPLs targeted to intercellular adhesion molecule-1 (ICAM-1), an endothelial leukocyte receptor upregulated on cerebral microvasculature during EAE, were administered to diseased mice. Fluorescence microscopy confirmed that fluorescently-tagged ACPLs were localized to central nervous system (CNS) microvasculature in a pattern consistent with ICAM-1 upregulation described immunohistochemically. High resolution MRI of mouse brains ex vivo demonstrated that ACPL binding conferred significant enhancement of signal intensity (SI) as compared to control images. These results suggest that ACPLs can be used as MRI contrast agents to visualize specific molecules expressed on vascular endothelium during disease.